Ebola.com sold for $200K

Not a bad piece of business.

The co-owner of Blue String Ventures, a Las Vegas-based company tells Yahoo Finance that it has sold the domain name Ebola.com for $200,000 to a marijuana company called Weed Growth Fund.

Sold to Weed Growth Fund. Okay... good. What else do we know?

Ebola.com is not the only disease-related site owned by Blue String Ventures. The company also owns the domain names birdflu.com and H1N1.com, but Hood points out that the company does not only focus on domains which refer to disease and tragedy. The company has sold various domain names for prices ranging from a few thousand to millions of dollars, he says.

Hood rejects the comparison of his company’s money-making pursuits to that of a weapons manufacturer. “This is our business model… it’s no different than buying a piece of real estate that we hope will appreciate. The fact that we have a handful of domain names that are about unpleasant topics doesn’t really qualify us as being in the business of trying to capitalize on any kind of tragedy.”

Source

Thoughts?

 

Occaecati voluptates aliquam quisquam laborum officiis labore. Inventore ipsum veniam sunt et et repellat. Dolore dolorem qui soluta quia eveniet facere dolores.

Robert Clayton Dean: What is happening? Brill: I blew up the building. Robert Clayton Dean: Why? Brill: Because you made a phone call.

Career Advancement Opportunities

April 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 99.0%
  • Warburg Pincus 98.4%
  • KKR (Kohlberg Kravis Roberts) 97.9%
  • Bain Capital 97.4%

Overall Employee Satisfaction

April 2024 Private Equity

  • The Riverside Company 99.5%
  • Blackstone Group 98.9%
  • KKR (Kohlberg Kravis Roberts) 98.4%
  • Ardian 97.9%
  • Bain Capital 97.4%

Professional Growth Opportunities

April 2024 Private Equity

  • The Riverside Company 99.5%
  • Bain Capital 99.0%
  • Blackstone Group 98.4%
  • Warburg Pincus 97.9%
  • Starwood Capital Group 97.4%

Total Avg Compensation

April 2024 Private Equity

  • Principal (9) $653
  • Director/MD (22) $569
  • Vice President (92) $362
  • 3rd+ Year Associate (90) $280
  • 2nd Year Associate (205) $268
  • 1st Year Associate (387) $229
  • 3rd+ Year Analyst (29) $154
  • 2nd Year Analyst (83) $134
  • 1st Year Analyst (246) $122
  • Intern/Summer Associate (32) $82
  • Intern/Summer Analyst (314) $59
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”